Logo
Homepage
Explore Our Models
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Genetic Disorders and Genomics
How to Choose the Best Knockout Cell Line Strategy
Cyagen Technical Content Team | June 10, 2025
Explore Ready-to-Use Mouse Models in MouseAtlas
Discover our extensive library of KO, cKO, and disease-specific mouse models. Accelerate your research with study-ready animals validated by scientists worldwide.
Explore Ready-to-Use Mouse Models in MouseAtlas
Contents
01. Comparing Gene Knockout and Gene Interference Models 02. What is a Frameshift Mutation? 03. What is Fragment Knockout? 04. Which is the Optimal Choice, Frameshift Mutation or Fragment Knockout? 05. How Cyagen Can Help You with Gene Knockout Cell Lines?
The traditional approaches used in gene function studies, especially in cell lines, include gene interference, gene overexpression, and gene knockout. Herein, we will focus on discussing the most popular approach, gene knockout – a mutation that inactivates a gene function.
Comparing Gene Knockout and Gene Interference Models

There may be confusion about gene knockout and gene interference models because of their similarities. However, gene interference only reduces gene expression at post-transcriptional level and cannot completely remove genes from the genome, as occurs in a gene knockout. Sometimes, if the background is not clean, it may be difficult to analyze the resulting phenotype. If protein expression cannot be decreased in gene interference experim

What is a Frameshift Mutation?

In the process of mRNA translation into protein, the amino acids that make up the protein are determined by three adjacent bases, known as codons, and the start codon of mRNA is generally AUG. When translation begins, the ribosome starts to translate from start codons, such as AUG and moves, along the mRNA, with every three adjacent bases determining an amino acid.

When a frameshift mutation occurs, the number of bases in the genome increases or decreases in a non-3 multiple, which shifts the codon reading frame. In this case, protein translation still starts from the start codon of AUG, but due to the addition or deletion of bases, the original gene sequence is destroyed, resulting in a complete change of the expressed protein sequence and even causing protein translation to end prematurely. In either case, the protein expressed by the original gene no longer exists, so we can consider that the gene has been knocked out.
What about situations wherein the base number to be added or deleted is a multiple of 3? This situation cannot be regarded as the frameshift mutation, unless the added or deleted base sequence is in the key functional domain of the protein. Otherwise, the protein obtained afterwards is still functional, so it cannot be regarded as a successful gene knockout. Theoretically, the incidence of non-frameshift mutation is 1/3, but in the process of gene knockout, we can screen out the mutant sequence to be a multiple of non-3 by sequencing, so as to ensure that the positive cloned cells have a frameshift mutation which results in a gene knockout.
What is Fragment Knockout?

Fragment knockout refers to the removal of one or more exon regions within a gene to achieve gene disruption. In our platform's fragment knockout workflow, two genomic targeting guides are designed to flank the region intended for deletion. These guides direct the nuclease-mediated cleavage of the genome at the specified sites, enabling removal of the intervening DNA segment.

Some may wonder if it is possible to knockout the whole gene instead of exon(s) only. Technically, it can be achieved, but the knockout of the entire gene fragment is time-consuming and laborious process, and sometimes it can make results unreliable. First, the difficulty of gene knockout will increase with the length of target fragment. Generally, the exon region of gene is relatively short, but the intron region is exceptionally large, which leads to a gene sequence consisting of at least 10 kb or more. In these cases, it becomes very difficult to knock out the whole gene. Moreover, the intron region of a gene may contain the regulatory elements of other genes, which affects the expression of other genes. If the whole gene is knocked out, it could affect the expression of other genes and influence credibility of the experimental results.

Which is the Optimal Choice, Frameshift Mutation or Fragment Knockout?

In gene knockout studies using cell lines, both frameshift mutation and fragment deletion strategies have their respective advantages depending on the experimental objectives. For many researchers—particularly those new to the field—it is essential to consult a broad range of literature and draw inspiration from existing experimental designs. However, when choosing between frameshift mutations and fragment knockouts, most publications do not explicitly state which method is optimal for achieving gene disruption.

For instance, one study investigating the role of DNA methyltransferases during mammalian development utilized a frameshift mutation approach for gene knockout. Yet, in the methods section, there was no explicit mention of why this strategy was chosen over fragment deletion, nor any comparison between the two.

In another publication focused on metabolic reprogramming in cancer cells, the authors designed two targeting guides to delete a small genomic fragment. Despite this, the study did not specify that a fragment knockout strategy was being employed, leaving room for interpretation.

These examples highlight a broader trend in the literature: researchers often do not emphasize whether frameshift mutations or fragment deletions are preferable. In practice, either method can be effective as long as it reliably disrupts gene function. The choice often depends on technical feasibility, target gene structure, and downstream validation strategies.

How Cyagen Can Help You with Gene Knockout Cell Lines?

We can perform a variety of knockout (KO) strategies to generate a custom cell line model, including frameshift mutation, large fragment knockout, and multiple genes knockout. We will adopt the best knockout strategy to greatly improve the success rate of target gene knockout and the expression efficiency according to each project's unique requirements.

>> Learn More About Cyagen Knockout Cell Line Services - Only $5599, KO Cell Lines

Subscribe to Receive Updates & Promotions From Cyagen
Subscribe
* Your privacy matters to us. We never share it with third parties.
Explore More
Unveiling the Secrets of the DIO-B6-M Mouse Model for Obesity Research
Spinocerebellar Ataxia Type III (SCA3) Research Model—B6-hATXN3 Mice
Vision Stolen by Years - Age-related Macular Degeneration
Y Maze Behavioral Task: Studying the function of spatial learning and memory in Neuroscience research
Share
Top
Ready to Elevate Your Research?
Discover how Cyagen can support your research. Let’s start a conversation.
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest